Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. / Kachuri, Linda; Johansson, Mattias; Rashkin, Sara R; Graff, Rebecca E; Bossé, Yohan; Manem, Venkata; Caporaso, Neil E; Landi, Maria Teresa; Christiani, David C; Vineis, Paolo; Liu, Geoffrey; Scelo, Ghislaine; Zaridze, David; Shete, Sanjay S; Albanes, Demetrius; Aldrich, Melinda C; Tardón, Adonina; Rennert, Gad; Chen, Chu; Goodman, Gary E; Doherty, Jennifer A; Bickeböller, Heike; Field, John K; Davies, Michael P; Dawn Teare, M; Kiemeney, Lambertus A; Bojesen, Stig E; Haugen, Aage; Zienolddiny, Shanbeh; Lam, Stephen; Le Marchand, Loïc; Cheng, Iona; Schabath, Matthew B; Duell, Eric J; Andrew, Angeline S; Manjer, Jonas; Lazarus, Philip; Arnold, Susanne; McKay, James D; Emami, Nima C; Warkentin, Matthew T; Brhane, Yonathan; Obeidat, Ma'en; Martin, Richard M; Relton, Caroline; Davey Smith, George; Haycock, Philip C; Amos, Christopher I; Brennan, Paul; Witte, John S; Hung, Rayjean J.
I: Nature Communications, Bind 11, 27, 2020.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
AU - Kachuri, Linda
AU - Johansson, Mattias
AU - Rashkin, Sara R
AU - Graff, Rebecca E
AU - Bossé, Yohan
AU - Manem, Venkata
AU - Caporaso, Neil E
AU - Landi, Maria Teresa
AU - Christiani, David C
AU - Vineis, Paolo
AU - Liu, Geoffrey
AU - Scelo, Ghislaine
AU - Zaridze, David
AU - Shete, Sanjay S
AU - Albanes, Demetrius
AU - Aldrich, Melinda C
AU - Tardón, Adonina
AU - Rennert, Gad
AU - Chen, Chu
AU - Goodman, Gary E
AU - Doherty, Jennifer A
AU - Bickeböller, Heike
AU - Field, John K
AU - Davies, Michael P
AU - Dawn Teare, M
AU - Kiemeney, Lambertus A
AU - Bojesen, Stig E
AU - Haugen, Aage
AU - Zienolddiny, Shanbeh
AU - Lam, Stephen
AU - Le Marchand, Loïc
AU - Cheng, Iona
AU - Schabath, Matthew B
AU - Duell, Eric J
AU - Andrew, Angeline S
AU - Manjer, Jonas
AU - Lazarus, Philip
AU - Arnold, Susanne
AU - McKay, James D
AU - Emami, Nima C
AU - Warkentin, Matthew T
AU - Brhane, Yonathan
AU - Obeidat, Ma'en
AU - Martin, Richard M
AU - Relton, Caroline
AU - Davey Smith, George
AU - Haycock, Philip C
AU - Amos, Christopher I
AU - Brennan, Paul
AU - Witte, John S
AU - Hung, Rayjean J
PY - 2020
Y1 - 2020
N2 - Impaired lung function is often caused by cigarette smoking, making it challenging to disentangle its role in lung cancer susceptibility. Investigation of the shared genetic basis of these phenotypes in the UK Biobank and International Lung Cancer Consortium (29,266 cases, 56,450 controls) shows that lung cancer is genetically correlated with reduced forced expiratory volume in one second (FEV1: rg = 0.098, p = 2.3 × 10-8) and the ratio of FEV1 to forced vital capacity (FEV1/FVC: rg = 0.137, p = 2.0 × 10-12). Mendelian randomization analyses demonstrate that reduced FEV1 increases squamous cell carcinoma risk (odds ratio (OR) = 1.51, 95% confidence intervals: 1.21-1.88), while reduced FEV1/FVC increases the risk of adenocarcinoma (OR = 1.17, 1.01-1.35) and lung cancer in never smokers (OR = 1.56, 1.05-2.30). These findings support a causal role of pulmonary impairment in lung cancer etiology. Integrative analyses reveal that pulmonary function instruments, including 73 novel variants, influence lung tissue gene expression and implicate immune-related pathways in mediating the observed effects on lung carcinogenesis.
AB - Impaired lung function is often caused by cigarette smoking, making it challenging to disentangle its role in lung cancer susceptibility. Investigation of the shared genetic basis of these phenotypes in the UK Biobank and International Lung Cancer Consortium (29,266 cases, 56,450 controls) shows that lung cancer is genetically correlated with reduced forced expiratory volume in one second (FEV1: rg = 0.098, p = 2.3 × 10-8) and the ratio of FEV1 to forced vital capacity (FEV1/FVC: rg = 0.137, p = 2.0 × 10-12). Mendelian randomization analyses demonstrate that reduced FEV1 increases squamous cell carcinoma risk (odds ratio (OR) = 1.51, 95% confidence intervals: 1.21-1.88), while reduced FEV1/FVC increases the risk of adenocarcinoma (OR = 1.17, 1.01-1.35) and lung cancer in never smokers (OR = 1.56, 1.05-2.30). These findings support a causal role of pulmonary impairment in lung cancer etiology. Integrative analyses reveal that pulmonary function instruments, including 73 novel variants, influence lung tissue gene expression and implicate immune-related pathways in mediating the observed effects on lung carcinogenesis.
KW - Adult
KW - Aged
KW - Female
KW - Forced Expiratory Volume
KW - Genetic Predisposition to Disease
KW - Humans
KW - Lung/physiopathology
KW - Lung Neoplasms/genetics
KW - Male
KW - Mendelian Randomization Analysis
KW - Middle Aged
KW - Phenotype
KW - Polymorphism, Single Nucleotide
KW - Prospective Studies
KW - Respiratory Function Tests
KW - Vital Capacity
U2 - 10.1038/s41467-019-13855-2
DO - 10.1038/s41467-019-13855-2
M3 - Journal article
C2 - 31911640
VL - 11
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 27
ER -
ID: 256323318